8,717 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Acquired by Shelton Capital Management

Shelton Capital Management acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 8,717 shares of the company’s stock, valued at approximately $338,000.

A number of other hedge funds have also recently bought and sold shares of BBWI. Golden State Wealth Management LLC bought a new stake in shares of Bath & Body Works during the fourth quarter worth approximately $26,000. SRS Capital Advisors Inc. grew its holdings in Bath & Body Works by 99.7% during the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after acquiring an additional 329 shares during the period. UMB Bank n.a. raised its position in shares of Bath & Body Works by 58.8% during the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after acquiring an additional 335 shares during the last quarter. Lindbrook Capital LLC lifted its stake in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the period. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Bath & Body Works in the 3rd quarter worth $39,000. 95.14% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

BBWI has been the subject of a number of recent analyst reports. TD Cowen upped their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Citigroup lowered their price target on Bath & Body Works from $48.00 to $36.00 and set a “buy” rating for the company in a research note on Monday. Telsey Advisory Group reissued an “outperform” rating and set a $43.00 price objective on shares of Bath & Body Works in a research note on Thursday, February 27th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. Finally, Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the stock an “outperform” rating in a research report on Friday, February 28th. Four equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $44.06.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $27.60 on Friday. Bath & Body Works, Inc. has a 52-week low of $24.96 and a 52-week high of $52.99. The business’s 50 day simple moving average is $33.24 and its 200 day simple moving average is $34.01. The firm has a market cap of $5.91 billion, a PE ratio of 6.73, a P/E/G ratio of 0.92 and a beta of 1.69.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. As a group, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.90%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s dividend payout ratio is currently 21.98%.

Bath & Body Works declared that its board has authorized a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to purchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.